Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
A pharmaceutical composition comprising an amphiphilic emulsifier, a polar liquid carrier and, optionally, a lipid component. The amphiphilic emulsifier form free-moving, optionally lipid-carrying, micelles (LMs) in the polar liquid carrier. The pharmaceutical composition is free of hemoglobin and fluorocarbon and can be used for treating conditions related to lack of blood supply and to raise the blood pressure and correct hypovolemia.
1. A method for treating conditions related to lack of blood supply, comprising:
administering to a subject in need of such treatment, an effectively amount of a pharmaceutical composition comprising:
an amphiphilic emulsifier; and
a polar liquid carrier,
wherein said amphiphilic emulsifier forms free-moving micelles having a lipophilic core in said polar liquid carrier and wherein said pharmaceutical composition is free of hemoglobin and fluorocarbon.
2. The method of claim 1 , wherein said pharmaceutical composition further comprises a lipid component and wherein said lipid component is present in said lipophilic core of said micelles.
3. The method of claim 2 , wherein said lipid component comprises soybean oil or an oil rich in omega 3 fatty acid.
4. The method of claim 3 , wherein said soybean oil or oil rich in omega 3 fatty acid is present in an amount of 10-70% (w/v) of said pharmaceutical composition.
5. The method of claim 3 , wherein said oil rich in omega 3 fatty acid is selected from the group consisting of chia bean oil, algae oil, pumpkin oil, flaxseed oil and fish oil.
6. The method of claim 1 , wherein said micelles have an average diameter in the range of 3-300 nm.
7. The method of claim 1 , wherein said pharmaceutical composition further comprises histidine or a histidine-containing peptide at a final concentration of 1 fM-100 mM.
8. The method of claim 1 , wherein said amphiphilic emulsifier comprises a phospholipid in an amount of 0.5-50% (w/v) of said pharmaceutical composition.
9. The method of claim 1 , wherein said pharmaceutical composition further comprises glycerol or mannitol in an amount of 2-15% (w/v) of said pharmaceutical composition and soybean oil in an amount of 20-35% (w/v) of said pharmaceutical composition, and wherein said micelles have an average diameter in the range of 3-300 nm.
10. The method of claim 1 , wherein said pharmaceutical composition comprises sodium ions at a concentration in the range of 70 mM to 160 mM.
11. The method of claim 10 , wherein said pharmaceutical composition comprises sodium chloride and sodium lactate.
12. A method for raising the blood pressure in a subject with hypovolemia, comprising:
administering to said subject, an effectively amount of a pharmaceutical composition comprising:
an amphiphilic emulsifier; and
a polar liquid carrier,
wherein said amphiphilic emulsifier forms free-moving micelles having a lipophilic core in said polar liquid carrier and wherein said pharmaceutical composition is free of hemoglobin and fluorocarbon.
13. The method of claim 12 , wherein said pharmaceutical composition further comprises a lipid component and wherein said lipid component is present in said lipophilic core of said micelles.
14. The method of claim 13 , wherein said lipid component comprises soybean oil or an oil rich in omega 3 fatty acid.
15. The method of claim 14 , wherein said soybean oil or an oil rich in omega 3 fatty acid is present in an amount of 10-70% (w/v) of said pharmaceutical composition.
16. The method of claim 14 , wherein said oil rich in omega 3 fatty acid is selected from the group consisting of chia bean oil, algae oil, pumpkin oil, flaxseed oil and fish oil.
17. The method of claim 12 , wherein said micelles have an average diameter in the range of 3-300 nm.
18. The method of claim 12 , wherein said pharmaceutical composition further comprises histidine or a histidine-containing peptide at a final concentration of 1 fM-100 mM.
19. The method of claim 12 , wherein said pharmaceutical composition comprises histidine amphiphilic emulsifier comprises a phospholipid in an amount of 0.5-50% (w/v) of said pharmaceutical composition.
20. The method of claim 12 , wherein said pharmaceutical composition further comprises glycerol or mannitol in an amount of 2-15% (w/v) of said pharmaceutical composition and soybean oil in an amount of 10-70%(w/v) of said pharmaceutical composition, and wherein said micelles have an average diameter in the range of 3-300 nm.
21. The method of claim 12 , wherein said pharmaceutical composition comprises sodium ions at a concentration in the range of 70 mM to 160 mM.
22. The method of claim 21 , wherein said pharmaceutical composition comprises sodium chloride and sodium lactate.